Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients.

Chou, Ruey-Hsing; Yang, Shang-Feng; Huang, Po-Hsun

Chou, Ruey-Hsing; Yang, Shang-Feng; Huang, Po-Hsun.

Afiliación

Chou RH; Department of Critical Care Medicine.
Yang SF; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.
Huang PH; Cardiovascular Research Center.

Acta Cardiol Sin ; 40(2): 260-261, 2024 Mar.

Article en En | MEDLINE | ID: mdl-38532818

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961638
https://dx.doi.org/10.6515/ACS.202403_40(2).20231206B

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Cardiol Sin Año: 2024 Tipo del documento: Article